Neuphoria Therapeutics Inc. — Investor Relations & Filings
Neuphoria Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing therapies for individuals affected by neuropsychiatric disorders. The company focuses on discovering and developing novel allosteric ion channel modulators to address unmet needs in mental health. Its lead product candidate, BNC210, is a first-in-class, anti-anxiety medication designed to restore balance in brain chemistry through a novel mechanism of action. BNC210 aims to provide rapid relief from anxiety symptoms without the common side effects of sedation, cognitive impairment, or addiction potential. The therapy is developed in a proprietary tablet formulation that allows for flexible, as-needed or regular dosing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - NEUPHORIA THERAPEUTICS INC. (0001191070) (Filer) | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-06 | English | |
| 4 Filing | 2026-01-21 | English | |
| 4 Filing | 2026-01-21 | English | |
| 4 Filing | 2026-01-21 | English | |
| 4 Filing | 2026-01-21 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 32888913 | 10-Q - NEUPHORIA THERAPEUTICS INC. (0001191070) (Filer) | 2026-02-17 | English | ||
| 28420021 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 28420103 | 4 Filing | 2026-01-21 | English | ||
| 28419996 | 4 Filing | 2026-01-21 | English | ||
| 28419995 | 4 Filing | 2026-01-21 | English | ||
| 28419976 | 4 Filing | 2026-01-21 | English | ||
| 32888912 | 8-K - NEUPHORIA THERAPEUTICS INC. (0001191070) (Filer) | 2026-01-07 | English | ||
|
2025
8 filings
| |||||
| 11555978 | Major Shareholding Notification 2025 | 2025-12-29 | English | ||
| 11555980 | CURRENT REPORT | 2025-12-18 | English | ||
| 11555981 | CURRENT REPORT | 2025-12-17 | English | ||
| 11555979 | DFAN14A | 2025-12-08 | English | ||
| 11555982 | DFAN14A | 2025-12-08 | English | ||
| 11555983 | DEFINITIVE ADDITIONAL MATERIALS | 2025-12-08 | English | ||
| 11555984 | DEFINITIVE ADDITIONAL MATERIALS | 2025-12-04 | English | ||
| 11555985 | DFAN14A | 2025-12-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Neuphoria Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34927/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34927 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34927 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34927 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34927}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Neuphoria Therapeutics Inc. (id: 34927)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.